Mitchell P. Kopin 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 5:29 pm Sale | 2025-09-30 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 695,715 9.990% | -19,129 (-2.68%) | Filing |
| 2025-01-15 4:03 pm Purchase | 2024-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 714,844 9.990% | 714,844 (New Position) | Filing |